Skip to main content

Kwietniak Matthew R.'s Form 4 filing

Avid Bioservices, Inc. (CDMO) · filed Jan 11, 2024

Accession no.
0001683168-24-000238
Filed
Jan 11, 2024
Trade date
Jan 9-10, 2024
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $6.54K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kwietniak Matthew R.CIK 0001974519Officer (Chief Commercial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 9, 2024Common Stock, $0.001 par valueMOption exerciseAcquired+1,261–F1–19,222Direct
Jan 9, 2024Common Stock, $0.001 par valueMOption exerciseAcquired+1,272–F1–20,494Direct
Jan 10, 2024Common Stock, $0.001 par valueSSaleDisposed−1,060$6.17F3−$6,540.219,434Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 9, 2024Common StockMOption exerciseDisposed−1,261$0.00$037,038Direct
Jan 9, 2024Common StockMOption exerciseDisposed−1,272$0.00$035,766Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.

Referenced by the price of 2 transactions in Table I.

F3

Represents a weighted average sales price per share. These shares were sold at prices ranging from $6.14 to $6.17. The reporting person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)